{"title":"使用以患者为中心的风险-收益结构和适当的生产实践(amp)成功开发和生产有效的细胞治疗产品","authors":"Mark Witcher, Nne Pharmaplan","doi":"10.12665/j152.witcher","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":"15 1","pages":"22-29"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Using a Patient-Centered Risk-Benefit Structure and Appropriate Manufacturing Practices (AMPs) for Successfully Developing and Manufacturing Effective Cell Therapy Products\",\"authors\":\"Mark Witcher, Nne Pharmaplan\",\"doi\":\"10.12665/j152.witcher\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":88836,\"journal\":{\"name\":\"Bioprocessing\",\"volume\":\"15 1\",\"pages\":\"22-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioprocessing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12665/j152.witcher\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioprocessing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12665/j152.witcher","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Using a Patient-Centered Risk-Benefit Structure and Appropriate Manufacturing Practices (AMPs) for Successfully Developing and Manufacturing Effective Cell Therapy Products